Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 3
2009 1
2010 2
2011 6
2012 6
2013 9
2014 9
2015 10
2016 13
2017 14
2018 25
2019 28
2020 24
2021 25
2022 29
2023 31
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Among authors: xu l. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
An Update on the Genetics of IgA Nephropathy.
Xu LL, Zhou XJ, Zhang H. Xu LL, et al. J Clin Med. 2023 Dec 25;13(1):123. doi: 10.3390/jcm13010123. J Clin Med. 2023. PMID: 38202130 Free PMC article. Review.
Circulating Proteins and IgA Nephropathy.
Tang C, Chen P, Xu LL, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H. Tang C, et al. J Am Soc Nephrol. 2024 Apr 30. doi: 10.1681/ASN.0000000000000379. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38687828
3CLpro inhibitors: DEL-based molecular generation.
Xiong F, Xu H, Yu M, Chen X, Zhong Z, Guo Y, Chen M, Ou H, Wu J, Xie A, Xiong J, Xu L, Zhang L, Zhong Q, Huang L, Li Z, Zhang T, Jin F, He X. Xiong F, et al. Among authors: xu l. Front Pharmacol. 2022 Dec 7;13:1085665. doi: 10.3389/fphar.2022.1085665. eCollection 2022. Front Pharmacol. 2022. PMID: 36569316 Free PMC article.
Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer's Disease.
Zhu L, Xu L, Wu X, Deng F, Ma R, Liu Y, Huang F, Shi L. Zhu L, et al. Among authors: xu l. ACS Appl Mater Interfaces. 2021 May 26;13(20):23328-23338. doi: 10.1021/acsami.1c00257. Epub 2021 May 17. ACS Appl Mater Interfaces. 2021. PMID: 33999598
Tailoring a Nanochaperone to Regulate α-Synuclein Assembly.
Wu X, Ma F, Pan BB, Zhang Y, Zhu L, Deng F, Xu L, Zhao Y, Yin X, Niu H, Su XC, Shi L. Wu X, et al. Among authors: xu l. Angew Chem Int Ed Engl. 2022 May 2;61(19):e202200192. doi: 10.1002/anie.202200192. Epub 2022 Mar 9. Angew Chem Int Ed Engl. 2022. PMID: 35229425
226 results